Gastroesophageal Reflux Disease (GERD)  -Epidemiology Forecast to 2028

"Gastroesophageal Reflux Disease (GERD) - Epidemiology Forecast, 2028 report provides a comprehensive analysis of the Gastroesophageal Reflux Disease (GERD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
United States
EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Japan

Study Period: 2016-2028

Gastroesophageal Reflux Disease (GERD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Gastroesophageal Reflux Disease (GERD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders views are also taken into account to provide a deep understanding of the Gastroesophageal Reflux Disease (GERD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Gastroesophageal Reflux Disease (GERD) scenario.

Gastroesophageal Reflux Disease (GERD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Gastroesophageal Reflux Disease (GERD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
The report covers detailed overview of Gastroesophageal Reflux Disease (GERD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
The Gastroesophageal Reflux Disease (GERD) Report assesses the disease risk and burden and highlights the unmet needs
It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
10 Year Forecast
7MM Coverage
Total Cases in Gastroesophageal Reflux Disease (GERD)

Key assessments
Patient Segmentation in Gastroesophageal Reflux Disease (GERD)
Gastroesophageal Reflux Disease (GERD) Risk & Burden
Factors driving growth in a specific Gastroesophageal Reflux Disease (GERD) patient population
1. Report Introduction
2. Gastroesophageal Reflux Disease (GERD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Gastroesophageal Reflux Disease (GERD) in 2016
2.2. Patient Share Distribution of Gastroesophageal Reflux Disease (GERD) in 2028
3. Disease Background and Overview: Gastroesophageal Reflux Disease (GERD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Gastroesophageal Reflux Disease (GERD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Gastroesophageal Reflux Disease (GERD) in 7MM By Countries
5. Epidemiology of Gastroesophageal Reflux Disease (GERD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.1.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) *
5.1.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD)*
5.1.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.4.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD)*
5.4.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD)*
5.4.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.5.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD)*
5.5.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD)*
5.5.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.6.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD)*
5.6.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD)*
5.6.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.7.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD)*
5.7.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD)*
5.7.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.8.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD)*
5.8.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD)*
5.8.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.9.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD)*
5.9.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD)*
5.9.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
6. Unmet Needs of the Gastroesophageal Reflux Disease (GERD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List Of Tables

Table 1: Total Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028) *
Table 14: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028)


List Of Figures

Figure 1: Total Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028)


Gastroesophageal (GE) Junction Carcinomas (Oncology) - Drugs in Development, 2021

Gastroesophageal (GE) Junction Carcinomas (Oncology) - Drugs in Development, 2021Gastroesophageal (GE) Junction Carcinomas (Oncology) - Drugs in Development, 2021 provides an overview of the Gastroesophageal (GE) Junction Carcinomas pipeline landscape.The

USD 2000 View Report

Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021

Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021 provides an overview of the Adenocarcinoma Of The Gastroesophageal

USD 2500 View Report

Global Gastroesophageal Reflux Disease Market Research Report 2021-2025

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Gastroesophageal Reflux Disease Report by Material, Application, and

USD 3200 View Report

Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021

Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Nonerosive Reflux Disease (NERD) pipeline landscape.The

USD 2000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available